Covid19NCT04534621
How Brazilian Chiropractors Are Facing the COVID-19 Pandemic
An observational study of Covid19, run by Trate - Tratamentos Especializados.
Trial summary
Brazil has the Latin America's largest coronavirus outbreak, numbers second only to the United States in the western hemisphere. The first COVID-19 confirmed case in Brazil was on February of 2020. A 61yrs old man tested positive after returning from a trip to Italy. Read more about this study
- Who is it for?
- Any ageHealthy volunteers can take part
- Conditions the study is for
- Covid19
- What is being tested?
- Electronic survey
- How many people
- 948 participants
- Where
- No sites listed yet
- Study dates
- 26 Aug 2020to 18 Sep 2020
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- Healthy volunteers accepted
- Child, Adult, Older adult
Study population: All chiropractors from the Brazilian Chiropractic association database / thru social media / principal investigator database will be invited to participate.
Who may be able to join
- Chiropractors graduated from national or international accredited colleges.
Who cannot join
- Chiropractors who did not treated patients in 2020.
Trial locations and contacts
No sites are listed yet.
About this study
Official title: How Brazilian Chiropractors Are Being Affected and What Strategies They Have Developed for Facing the COVID-19 Pandemic
Brazil has the Latin America's largest coronavirus outbreak, numbers second only to the United States in the western hemisphere. The first COVID-19 confirmed case in Brazil was on February of 2020. A 61yrs old man tested positive after returning from a trip to Italy. Few other very first cases were also imported from Europe by returning travelers. The first locally transmitted case was registered on March of 2020, when a total of 8 cases have already been confirmed. At the time the WHO declares the outbreak as a pandemic (March 11) Brazil had 52 confirmed cases being 6 of those locally transmitted.
Healthcare professionals are now more important than ever. Given the intrinsic nature of the hands-on treatment of the Chiropractic profession, it is extremely important to understand what strategies chiropractors have put in place to address patient care, safety, and self report COVID contamination of those professionals.
- Conditions
- Covid19
- Being tested
- Electronic survey
- Keywords
- chiropractors, strategies, coronavirus, pandemic
- Medical subject headings
- COVID-19, Coronavirus Infections
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Electronic surveyOther
Brazilian chiropractors will be invited by email and social media to answer an electronic survey.
| Study group | Role | What they receive |
|---|---|---|
| Brazilian chiropractors | A cross-sectional survey will be performed with this population (Brazilian chiropractors) to assess outcomes regarding what is the current impact and what measures they have implemented while facing the COVID-19 pandemic. Receives: Other: Electronic survey |
What is being measured
The primary outcome is the main question the study is designed to answer.
What measures have been implemented to avoid SARS-COV2 transmission when taking care of patients, during the COVID-19 pandemic.
Subjects will answer a online survey addressing what measures they have implemented to prevent SARS-COV2 contamination among staff and patients, when taking care of patients. These questions address the use of individual protection devices, sanitizing methods, social distancing, patient orientation, and consultation time. These will be analyzed in conjunct, using descriptive statistics.
Measured: 2 weeks
Secondary outcomes (2)
Professionals SARS-COV2 infection rates.
Self declared SARS-COV2 infection rates.
Measured: 2 weeks
Professional financial impact.
To assess the potential professional financial impact caused by the pandemic, the subjects will answer a question in the survey addressing if they have had a financial loss during the pandemic. This question will have the following answer options: no financial loss, less than 25% financial loss, between 25-50%, between 50-75%, more than 75% of financial loss due the pandemic.
Measured: 2 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted1 Sep 2020
- Study start26 Aug 2020 (estimated)
- Primary completion6 Sep 2020 (estimated)
- Study completion18 Sep 2020 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Covid19Studies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Cross-sectional
- Enrolment
- 948 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Trate - Tratamentos Especializados
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Marcelo Borges Botelho, Trate - Tratamentos Especializados
- Investigators
- MARCELO B BOTELHO, DC, MD, MSc, Principal investigator, Trate
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04534621
- Sponsor's protocol ID
- TrateTE
- Status last verified
- Aug 2020
- First submitted
- 25 Aug 2020
- Last updated
- 1 Sep 2020
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Collective / group data sharing only.
Study at a glance
From the registry record, last updated by the sponsor on 1 Sep 2020. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- How Brazilian Chiropractors Are Being Affected and What Strategies They Have Developed for Facing the COVID-19 Pandemic
- ClinicalTrials.gov ID
- NCT04534621
- Acronym / sponsor ID
- TrateTE
- Conditions
- Covid19
- Keywords
- chiropractors, strategies, coronavirus, pandemic
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 948 participants (estimated)
- Lead sponsor
- Trate - Tratamentos EspecializadosUniversity, hospital or other
- Study start
- 26 Aug 2020 (estimated)
- Primary completion
- 6 Sep 2020 (estimated)
- Study completion
- 18 Sep 2020 (estimated)
- First posted
- 1 Sep 2020 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Brazil has the Latin America's largest coronavirus outbreak, numbers second only to the United States in the western hemisphere. The first COVID-19 confirmed case in Brazil was on February of 2020. A 61yrs old man tested positive after returning from a trip to Italy. Few other very first cases were also imported from Europe by returning travelers. The first locally transmitted case was registered on March of 2020, when a total of 8 cases have already been confirmed. At the time the WHO declares the outbreak as a pandemic (March 11) Brazil had 52 confirmed cases being 6 of those locally transmitted.
Healthcare professionals are now more important than ever. Given the intrinsic nature of the hands-on treatment of the Chiropractic profession, it is extremely important to understand what strategies chiropractors have put in place to address patient care, safety, and self report COVID contamination of those professionals.
Study design
- Observational model
- Other
- Time perspective
- Cross-sectional
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Brazilian chiropractors | – | Other: Electronic surveyA cross-sectional survey will be performed with this population (Brazilian chiropractors) to assess outcomes regarding what is the current impact and what measures they have implemented while facing the COVID-19 pandemic. |
Who may qualify
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
- Study population
- All chiropractors from the Brazilian Chiropractic association database / thru social media / principal investigator database will be invited to participate.
Key inclusion criteria (1 listed)
- Chiropractors graduated from national or international accredited colleges.
Key exclusion criteria (1 listed)
- Chiropractors who did not treated patients in 2020.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Electronic surveyBrazilian chiropractors will be invited by email and social media to answer an electronic survey. | Other | Brazilian chiropractors |
Primary outcome
What measures have been implemented to avoid SARS-COV2 transmission when taking care of patients, during the COVID-19 pandemic.
Time frame: 2 weeks
Subjects will answer a online survey addressing what measures they have implemented to prevent SARS-COV2 contamination among staff and patients, when taking care of patients. These questions address the use of individual protection devices, sanitizing methods, social distancing, patient orientation, and consultation time. These will be analyzed in conjunct, using descriptive statistics.
2 secondary outcomes
Professionals SARS-COV2 infection rates.
Time frame: 2 weeks
Professional financial impact.
Time frame: 2 weeks
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 1 Sep 2020.
- Individual participant dataSharing planned: No. Collective / group data sharing only.
Related trials for Covid19
Not yet recruitingPhase 1
Phase I Open-Label Safety Trial of Pembrolizumab for Neurological Post- Acute Sequelae of SARS-CoV-2 (PD1-PASC I)
Post-Acute COVID-19 Syndrome
Active, not recruitingPhase 1
A Safety and Immunogenicity Trial of OCU500, ChAd36 Vector Encoding SARS-CoV-2 Spike Vaccine Via Intranasal and Inhalational Routes in Previously Vaccinated Adults
COVID-19
Active, not recruiting
Intervention to Address Disparate Mental Health Consequences of COVID-19 Pandemic on Latinx and African Newcomers
Mental Health Issue, Mental Health Disorder
Recruiting
Home-Based Exercise Tele-Rehabilitation After COVID-19
Post SARS-CoV2 (COVID-19)
Not yet recruitingPhase 1
A Safety, Reactogenicity and Immunogenicity Trial of RVX-sCPD9 Booster Intranasal COVID-19 Vaccine
COVID -19
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
MARCELO B BOTELHO, DC, MD, MSc principal investigator
Trate
Questions about this trial
What is this clinical trial studying?
An observational study of Covid19, run by Trate - Tratamentos Especializados.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 1 Sep 2020. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact MARCELO B BOTELHO, DC, MD, MSc (7132617799, quiropraxia@hotmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
What measures have been implemented to avoid SARS-COV2 transmission when taking care of patients, during the COVID-19 pandemic. (time frame: 2 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Sep 2020.